anti-CD306 antibody product blog
Tags: Antibody; Polyclonal Antibody; CD306; anti-CD306 antibody;
The CD306 n/a (Catalog #MBS6003063) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The CD306 (Leukocyte-associated Immunoglobulin-like Receptor 2, LAIR2, LAIR-2, MGC71634) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s CD306 can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB).Suitable for use in Western Blot. Researchers should empirically determine the suitability of the CD306 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. The amino acid sequence is listed below:
MSPHLTALLG LVLCLAQTIH TQEGALPRPS ISAEPGTVIS PGSHVTFMCR GPVGVQTFRL EREDRAKYKD SYNVFRLGPS ESEARFHIDS VSEGNAGLYR CLYYKPPGWS EHSDFLELLV KESSGGPDSP DTEPGSSAGT VPGTEASGFD AP.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the CD306 (Leukocyte-associated Immunoglobulin-like Receptor 2, LAIR2, LAIR-2, MGC71634) with the following immunoassay(s):
Western Blot (WB) (Western Blot analysis of LAIR2 expression in transfected 293T cell line by LAIR2 polyclonal antibody. Lane 1: LAIR2 transfected lysate (16.72kD). Lane 2: Non-transfected lysate.)
Immunogen: Full length human LAIR2, aa1-152 (NP_002279.2). In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing CD306 are readily searchable from our website. Different antibodies against the same target such as CD306 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.